Cargando…
NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
For successful immunotherapy for cancer, it is important to understand the immunological status of tumor antigen‐specific CD8(+) T cells in the tumor microenvironment during tumor progression. In this study, we monitored the behavior of B16OVA‐Luc cells in mice immunized with a model tumor antigen o...
Autores principales: | Mojic, Marija, Shitaoka, Kiyomi, Ohshima, Chikako, Ucche, Sisca, Lyu, Fulian, Hamana, Hiroshi, Tahara, Hideaki, Kishi, Hiroyuki, Hayakawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409295/ https://www.ncbi.nlm.nih.gov/pubmed/34187084 http://dx.doi.org/10.1111/cas.15050 |
Ejemplares similares
-
Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
por: Kishi, Hiroyuki, et al.
Publicado: (2015) -
Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model
por: Dung, Nguyen Tien, et al.
Publicado: (2023) -
The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
por: Mojic, Marija, et al.
Publicado: (2017) -
NKG2D function protects the host from tumor initiation
por: Smyth, Mark J., et al.
Publicado: (2005) -
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
por: Smyth, Mark J., et al.
Publicado: (2004)